Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series - Poll - MDSpire

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series

  • By

  • Giulia Odorici

  • Cinzia Buligan

  • Carolina Fantini

  • Lucia Mantovani

  • Giulia Rech

  • Lidia Sacchelli

  • July 14, 2026

Share

Original Source(s)

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series

  • by Giulia Odorici, Cinzia Buligan, Carolina Fantini, Lucia Mantovani, Giulia Rech, Lidia Sacchelli

  • July 14, 2026

Related Content

T helper 17 cells and group 3 innate lymphoid cells define a spectrum of psoriasis endotypes

Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes

Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient